Key features include: * Inclusion of newly recognized neuropathies ie multifocal neuropathy, neuropathies associated with AIDS and with Borreliiosis and neuropathies due to previously uncharacterised neurotoxins * The identification of the genetic factors resposible for hereditary neuropathies * New information on the role of neurotrophic factors and their receptors * Coverage of the major debates surrounding antibody associated neuropathies * Discusion of the therapeutic advances in the treatment of Guillain-Barre disease and in diabetic neuropathy